Dr Alexander Lyon studied medicine at Oxford University, UK, where he was awarded a first-class degree in physiological sciences in 1995. After qualifying from the John Radcliffe Medical School in 1998, he trained as a junior doctor in cardiology in Oxford, London (Royal Brompton Hospital) and Sydney, Australia. He was awarded an MRC Clinical Research Training Fellowship in 2005 and completed his PhD in 2008 at Mount Sinai School of Medicine, New York, USA. He was appointed Walport Clinical Lecturer in Cardiology at Imperial College in October 2008, and he completed his cardiology training at St Mary’s Hospital and Royal Brompton Hospital. He was appointed a senior lecturer and consultant cardiologist at Royal Brompton Hospital, UK, in January 2012.
Dr Lyon's clinical expertise includes heart failure, chemotherapy-induced heart failure, Takotsubo syndrome, cardiac gene therapy and novel molecular and biological therapies for heart failure. Dr Lyon is lead for the heart failure research theme of the National Institute of Health Research (NIHR) cardiovascular biomedical research unit (cBRU) and clinical lead for the cardio-oncology service, Royal Brompton Hospital (2011-present). He is chair of UK Cardio-Oncology Consortium and a member of Heart Failure Association Translational Research Committee. Dr Lyon has presented at numerous national and international meetings and has reviewed manuscripts for various scientific journals. Dr Lyon has received a number of academic awards throughout his career.